Laurent Servais

15.1k total citations · 3 hit papers
292 papers, 5.6k citations indexed

About

Laurent Servais is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Laurent Servais has authored 292 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 185 papers in Molecular Biology, 142 papers in Genetics and 57 papers in Surgery. Recurrent topics in Laurent Servais's work include Neurogenetic and Muscular Disorders Research (139 papers), Muscle Physiology and Disorders (93 papers) and RNA modifications and cancer (58 papers). Laurent Servais is often cited by papers focused on Neurogenetic and Muscular Disorders Research (139 papers), Muscle Physiology and Disorders (93 papers) and RNA modifications and cancer (58 papers). Laurent Servais collaborates with scholars based in Belgium, United Kingdom and France. Laurent Servais's co-authors include Guy Chéron, Tamara Dangouloff, Bernard Dan, Teresa Gidaro, Serge N. Schiffmann, Eugenio Mercuri, Sithara Ramdas, David Gall, Thomas Voit and Francesco Muntoni and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Laurent Servais

263 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risdiplam in Type 1 Spinal Muscular Atrophy

2021 260 citations Giovanni Baranello, John Day et al. profile →
Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial

2022 168 citations Francesco Muntoni, Kayoko Saito et al. profile →
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls

2021 160 citations Giovanni Baranello, Marianne Gerber et al. profile →

Peers

Countries citing papers authored by Laurent Servais

Since Specialization

Citations

This map shows the geographic impact of Laurent Servais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Servais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Servais more than expected).

Fields of papers citing papers by Laurent Servais

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Servais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Servais. The network helps show where Laurent Servais may publish in the future.

Co-authorship network of co-authors of Laurent Servais

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Servais. A scholar is included among the top collaborators of Laurent Servais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Servais. Laurent Servais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pushing the boundaries: future directions in the management of spinal muscular atrophy 2025 ·Trends in Molecular Medicine ·Fiona Moultrie, (unknown), (unknown), C. Lilien, Laurent Servais	4
2	A systematic review of immunosuppressive protocols used in AAV gene therapy for monogenic disorders 2024 ·Molecular Therapy ·(unknown), (unknown), (unknown), Christopher P Webster, Eli Harriss, Fraser McBlane, Corinne Betts, Jorge Schettini, (unknown), John E. Mindur, (unknown), Pamela J. Shaw, Janine Kirby, Mimoun Azzouz, Laurent Servais	24
3	Biological biomarkers in muscle diseases relevant for follow-up and evaluation of treatment 2024 ·Brain ·(unknown), Giorgio Tasca, Nils Erik Gilhus, Laurent Servais, (unknown), Lorenzo Maggi, Valeria Sansone, John Vissing	0
4	Impact of Disease Severity and Disease-Modifying Therapies on Myostatin Levels in SMA Patients 2024 ·International Journal of Molecular Sciences ·(unknown), Virginie Mariot, (unknown), Laurent Servais, Julie Dumonceaux	3
5	A Systematic Literature Review of the Natural History of Respiratory, Swallowing, Feeding, and Speech Functions in Spinal Muscular Atrophy (SMA) 2024 ·Journal of Neuromuscular Diseases ·(unknown), (unknown), Sarah Batson, Stephen Mitchell, Ksenija Gorni, (unknown), Maryam Oskoui, Laurent Servais, Nicolas Deconinck, Katlyn McGrattan, Eugenio Mercuri, C. Simone Sutherland	10
6	Meaningful changes in motor function in Duchenne muscular dystrophy (DMD): A multi-center study 2024 ·PLoS ONE ·Francesco Muntoni, James Signorovitch, Gautam Sajeev, Nicolae Done, Zhiwen Yao, Nathalie Goemans, Craig M. McDonald, Eugenio Mercuri, E. Niks, Brenda Wong, Krista Vandenborne, Volker Straub, Imelda J. M. de Groot, Cuixia Tian, Adnan Manzur, (unknown), H. Clifford Lane, Susan J. Ward, Laurent Servais, (unknown), (unknown), (unknown)	7
7	Cerebellar dysfunction in the mdx mouse model of Duchenne muscular dystrophy: An electrophysiological and behavioural study 2024 ·European Journal of Neuroscience ·(unknown), (unknown), Ana Maria Cebolla, Nicolas Deconinck, Laurent Servais, (unknown), Bernard Dan, Guy Chéron	1
8	2024 update: European consensus statement on gene therapy for spinal muscular atrophy 2024 ·European Journal of Paediatric Neurology ·Janbernd Kirschner, Günther Bernert, (unknown), Liesbeth De Waele, Aviva Fattal‐Valevski, Jana Haberlová, T. Moreno, Andrea Klein, Anna Kostera‐Pruszczyk, Eugenio Mercuri, Susana Quijano‐Roy, Thomas Sejersen, Eduardo F. Tizzano, W. Ludo van der Pol, Sean Wallace, Dimitrios Zafeiriou, Andreas Ziegler, Francesco Muntoni, Laurent Servais	10
9	Sunfish parts 1 and 2: 4-year efficacy and safety data of risdiplam in types 2 and 3 spinal muscular atrophy (SMA) 2023 ·Journal of the Neurological Sciences ·Maryam Oskoui, Nicolas Deconinck, Elena Mazzone, A. Nascimento, John Day, Kayoko Saito, Carole Vuillerot, Giovanni Baranello, Odile Boespflug‐Tanguy, Nathalie Goemans, Janbernd Kirschner, Anna Kostera‐Pruszczyk, Laurent Servais, (unknown), Marianne Gerber, Ksenija Gorni, Carmen Martín, Wai Yin Yeung, R. Scalco, Eugenio Mercuri	2
10	261st ENMC International Workshop: Management of safety issues arising following AAV gene therapy. 17th-19th June 2022, Hoofddorp, The Netherlands 2023 ·Neuromuscular Disorders ·Laurent Servais, Rebecca H. Horton, Dimah Saade, Carsten G. Bönnemann, Francesco Muntoni, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	16
11	Novel Therapeutic Approaches in Inherited Neuropathies: A Systematic Review 2023 ·Pharmaceutics ·(unknown), (unknown), Laurent Servais	4
12	Spinal Muscular Atrophy Treatment in Patients Identified by Newborn Screening—A Systematic Review 2023 ·Genes ·(unknown), (unknown), Tamara Dangouloff, Laurent Servais	44
13	Risdiplam: an investigational survival motor neuron 2 (SMN2) splicing modifier for spinal muscular atrophy (SMA) 2022 ·Expert Opinion on Investigational Drugs ·(unknown), (unknown), Sithara Ramdas, Laurent Servais	23
14	Normalized grip strength is a sensitive outcome measure through all stages of Duchenne muscular dystrophy 2020 ·Journal of Neurology ·Jean‐Yves Hogrel, V. Decostre, Isabelle Ledoux, Marie De Antonio, E. Niks, Imelda J. M. de Groot, Volker Straub, Francesco Muntoni, Valeria Ricotti, Thomas Voit, A. Seferian, Teresa Gidaro, Laurent Servais	16
15	Novel Free-Circulating and Extracellular Vesicle-Derived MiRNAs Dysregulated in Duchenne Muscular Dystrophy 2020 ·Epigenomics ·Francesco Catapano, (unknown), (unknown), (unknown), Joana Domingos, (unknown), Valeria Ricotti, Lauren Phillips, Laurent Servais, A. Seferian, Imelda J. M. de Groot, Yvonne D. Krom, Thomas Voit, Jan J.G.M. Verschuuren, E. Niks, Volker Straub, Jennifer E. Morgan, Francesco Muntoni	5
16	Abstracts from “Imaging in Neuromuscular Disease 2019: Second International Conference on Imaging in Neuromuscular Disease, 17^th – 19^th November 2019 \| Berlin, Germany” 2019 ·Journal of Neuromuscular Diseases ·Harmen Reyngoudt, Benjamin Marty, (unknown), (unknown), (unknown), Pierre‐Yves Baudin, Brenda Wong, Tanja Stojković, (unknown), Teresa Gidaro, Laurent Servais, Yves Allenbach, (unknown), (unknown)	1
17	Quantitative nuclear magnetic resonance imaging detects subclinical changes over 1 year in skeletal muscle of GNE myopathy 2019 ·Journal of Neurology ·Teresa Gidaro, Harmen Reyngoudt, (unknown), Anthony Béhin, Férial Toumi, (unknown), Ericky Caldas de Almeida Araújo, Pierre‐Yves Baudin, Benjamin Marty, M. Annoussamy, Jean‐Yves Hogrel, Pierre G. Carlier, Laurent Servais	12
18	RNA-Seq Analysis of an Antisense Sequence Optimized for Exon Skipping in Duchenne Patients Reveals No Off-Target Effect 2017 ·Molecular Therapy — Nucleic Acids ·Claire Domenger, (unknown), Virginie François, Adrien Léger, (unknown), Marie Montus, Laurent Servais, Thomas Voit, Philippe Moullier, Yann Audic, Caroline Le Guiner	7
19	Sexual life in subjects with intellectual disability La vida sexual de las personas con discapacidad intelectual 2008 ·SHILAP Revista de lepidopterología ·(unknown), Laurent Servais	0
20	Role of calcium binding proteins in the control of cerebellar granule cell neuronal excitability: experimental and modeling studies 2005 ·Progress in brain research ·David Gall, Céline Roussel, Thierry Nieus, Guy Chéron, Laurent Servais, Egidio D’Angelo, Serge N. Schiffmann	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact